Buy 5 or More Products! Save 25% On Total.
 Buy 3 or More Products! Save 10% On Total.
 Free Shipping! No Minimum Order.


Buy MPJE Quizzes
Blog Empty Image

All prescription drug orders communicated by way of electronic transmission shall:

I. Be transmitted only by an authorized practitioner or practitioner's designated agent.
II. Be transmitted directly to a pharmacist in a pharmacy of the patient’s choice.
III. Specify the prescribing practitioner’s telephone number for verbal confirmation.


All prescription drug orders communicated by way of electronic transmission shall:

I. Be transmitted only by an authorized practitioner or practitioner's designated agent.
II. Be transmitted directly to a pharmacist in a pharmacy of the patient’s choice.
III. Specify the prescribing practitioner’s telephone number for verbal confirmation.

a. I only
b. III only
c. I and II only
d. II and III only
e. All

Answer:


Blog Empty Image

Oregonians who may suffer agitation due to Alzheimer's disease can use small amounts of marijuana without fear of civil or criminal penalties if their doctors advise that such use may provide a medical benefit to them.

Tue or False


Oregonians who may suffer agitation due to Alzheimer's disease can use small amounts of marijuana without fear of civil or criminal penalties if their doctors advise that such use may provide a medical benefit to them.

Tue or False


Blog Empty Image

A pharmacist licensed in Illinois may fill or refill a valid prescription for Ambien which is on file in a pharmacy licensed in North Carolina.

True or False


A pharmacist licensed in Illinois may fill or refill a valid prescription for Ambien which is on file in a pharmacy licensed in North Carolina.

True, [Illinois Pharmacy Practice Act 225 ILCS 85/19(5)].

Nothing contained in this Act shall be construed to prohibit a pharmacist licensed in this State from filling or refilling a valid prescription for prescription drugs which is on file in a pharmacy licensed in any state and has been transferred from one pharmacy to another by any means, including by way of electronic data processing equipment upon the following conditions and exceptions:

(1). Prior to dispensing pursuant to any such prescription, the dispensing pharmacist shall:

(a). Advise the patient that the prescription on file at such other pharmacy must be canceled before he or she will be able to fill or refill it.

(b). Determine that the prescription is valid and on file at such other pharmacy and that such prescription may be filled or refilled, as requested, in accordance with the prescriber's intent expressed on such prescription.

(c). Notify the pharmacy where the prescription is on file that the prescription must be canceled.

(d). Record in writing the prescription order, the name of the pharmacy at which the prescription was on file, the prescription number, the name of the drug and the original amount dispensed, the date of original dispensing, and the number of remaining authorized refills.

(e). Obtain the consent of the prescriber to the refilling of the prescription when the prescription, in the professional judgment of the dispensing pharmacist, so requires.

When filling or refilling a valid prescription on file in another state, the dispensing pharmacist shall be required to follow all the requirements of Illinois law which apply to the dispensing of prescription drugs. If anything in Illinois law prevents the filling or refilling of the original prescription it shall be unlawful to dispense pursuant to this Section.

Prescriptions for drugs in Schedules III, IV, and V of the Illinois Controlled Substances Act may be transferred only once and may not be further transferred. However, pharmacies electronically sharing a real-time, online database may transfer up to the maximum refills permitted by the law and the prescriber's authorization.


Blog Empty Image

It shall be unlawful for any distributor of a prescription drug to distribute a prescription drug without charge or for less than its fair market value to a patient by a pharmacist in response to a request written and signed by a medical practitioner which designates the quantity to be distributed.

True or False


It shall be unlawful for any distributor of a prescription drug to distribute a prescription drug without charge or for less than its fair market value to a patient by a pharmacist in response to a request written and signed by a medical practitioner which designates the quantity to be distributed.

False, [Illinois Pharmacy Practice Act 225 ILCS 85/24].

It shall be unlawful for any manufacturer or distributor of a prescription drug, or any person on behalf of such manufacturer or distributor, to distribute a prescription drug without charge or for less than its fair market value to any person directly or indirectly. Nothing in this Section shall be construed to PROHIBIT the distribution of a prescription drug:

(a). at a discount in accordance with the laws of the United States or the State of Illinois;

(b). to a person for use in an investigation conducted under Federal Food and Drug Administration regulations;

(c). to a patient by a pharmacist in response to a request written and signed by a medical practitioner which designates the quantity to be distributed;

(d). to a licensed medical practitioner in response to a request signed by the practitioner which designates the quantity to be distributed;

(e). to an agency of the federal government or to a state government or political subdivision for regulatory or enforcement purposes;

(f). in an emergency as determined by the laws of the United States or the State of Illinois; or

(g). to a bona fide charity authorized to possess and dispense prescription drugs.


Blog Empty Image

Topic: Medication Error/Inattentional blindness/Tennessee Board of Pharmacy 2012 December News Letter

A pharmacist enters a prescription for methotrexate daily into the pharmacy computer.A dose warning appears on the screen. The pharmacist reads the warning, bypasses it, and dispenses the medication as entered. The patient receives an overdose of the medication and dies...


Topic: Medication Error/Inattentional blindness/Tennessee Board of Pharmacy 2012 December News Letter

A pharmacist enters a prescription for methotrexate daily into the pharmacy computer.A dose warning appears on the screen. The pharmacist reads the warning, bypasses it, and dispenses the medication as entered. The patient receives an overdose of the medication and dies.

This error, and many more, have happened because the person performing the task fails to see what should have been plainly visible, and later, they cannot explain the lapse. People involved in these errors have been labeled as careless and negligent. But these types of accidents are common – even with intelligent, vigilant, and attentive people. The cause is usually rooted in inattentional blindness.

Accidents happen when attention mistakenly filters away important information and the brain fills in the gaps with what is aptly referred to as a "grand illusion." Thus, in the example above, the brain of the pharmacist filtered out important information on the computer screen,and filled in the gaps with erroneous information that led him to believe he had read the warning appropriately.

Inattentional blindness is more likely to occur if part of your attention is diverted to secondary tasks, like answering the phone while entering prescriptions into the computer, or even thinking about your dinner plans while transcribing an order.

Low workload causes boredom and reduces the mental attention given to tasks, as does carrying out highly practiced tasks, such as counting out medication. We spend a large majority of our waking life functioning with the equivalent of an automatic pilot, with occasional conscious checks to ensure tasks are being carried out properly. This makes us particularly prone to inattentional blindness.


Blog Empty Image

Pharmacists, pharmacy interns and pharmacy technicians may transfer a prescription containing a Schedule II controlled substance with any other drug that is a non-scheduled prescription drug to another prescription form under Tennessee Pharmacy Practice Act.

True or False


Pharmacists, pharmacy interns and pharmacy technicians may transfer a prescription containing a Schedule II controlled substance with any other drug that is a non-scheduled prescription drug to another prescription form under Tennessee Pharmacy Practice Act.

True, [Tennessee Pharmacy Practice Act of 1996 63-10-215].

(a). Pharmacists, pharmacy interns and pharmacy technicians may transfer a prescription containing a Schedule Il controlled substance with any other drug that is a non-scheduled prescription drug to another prescription form under Tennessee Pharmacy Practice Act.

(b). The transfer authorized in subsection (a) may be accomplished by scanning, photocopying or transcribing, by hand or other means, and shall include all information regarding each drug or supply being transferred.

(c). The prescription generated in a pharmacy by the transfer process shall not be required to be on tamper-resistant prescription paper.

(d). The prescription generated in a pharmacy utilizing the transfer process shall be recognized as a valid, legal prescription order and shall serve as the original prescription for recordkeeping and other purposes.


Blog Empty Image

In Tennessee, an Institutional Pharmacy setting, a prescription order that is ordered and administered before the pharmacist’s review; such order shall be reviewed by a pharmacist no later than 72 hours.

True or False


In Tennessee, an Institutional Pharmacy setting, a prescription order that is ordered and administered before the pharmacist’s review; such order shall be reviewed by a pharmacist no later than 72 hours.

False, [Rules of the Tennessee Board of Pharmacy 1140-4-.04].

A pharmacist shall review all prescription orders before the drug is first dispensed. In the event that medications available in the institutional facility are ordered and administered before the pharmacist’s review, the order shall be reviewed by a pharmacist in a timely manner (No time limit such as within 72 hours).

The pharmacist shall have access to the patient’s medical record.

The original order must be maintained in a readily retrievable manner according to the pharmacy practice site policy for at least two (2) years from the date of its issuance.


Blog Empty Image

Which of the following pharmacies may perform a prospective drug review in a Centralized Processing System?


Which of the following pharmacies may perform a prospective drug review in a Centralized Processing System?

a. Central Processing Pharmacy
b. Central Fill Pharmacy
c. Dispensing Pharmacy
d. Intake Pharmacy

Answer: (a). Central Processing Pharmacy, [New Jersey Administrative Code 13:39 4.19].

The four component functions of handling a prescription in centralized processing system are intake, processing, fulfillment and dispensing.

Central prescription handling entails two or more licensed pharmacies sharing responsibility for performing the four component functions of handling a prescription.

The following pharmacies may engage in central prescription handling: an intake or originating pharmacy; a central processing pharmacy; a central fill pharmacy; and a dispensing pharmacy.

The four component functions of handling a prescription shall be performed by the following pharmacies:

1). An intake or originating pharmacy, which is a pharmacy that received the patient's or prescribing practitioner's request to fill or refill a prescription.

1A). A central processing pharmacy or a central fill pharmacy may be considered the intake or originating pharmacy if the prescription was transmitted by the prescribing practitioner directly to the centralized pharmacy or if the patient requested the refill from that pharmacy;

2). A central processing pharmacy, which is a pharmacy that engages in prescription review by performing functions that may include, but are not limited to, data entry, prospective drug review, refill authorizations, interventions, patient counseling, claims submission, claims resolution and adjudication;

3). A central fill pharmacy, which is a pharmacy engaging in central prescription handling by filling and/or refilling prescriptions, which includes the preparation and packaging of the medication; and

4). A dispensing pharmacy, which is a pharmacy that receives the processed prescription and/or the filled or refilled prescription for dispensing to the patient or to the patient's authorized representative and that offers patient counseling regarding the dispensed medication.


Blog Empty Image

In New Jersey, if a pharmacist completes a number of continuing education credit hours in excess of the number required for a biennial period, the Board may allow credits to be carried over to satisfy the pharmacist's continuing education requirement for the next biennial renewal period.

a. True
b. False

Answer:


In New Jersey, if a pharmacist completes a number of continuing education credit hours in excess of the number required for a biennial period, the Board may allow credits to be carried over to satisfy the pharmacist's continuing education requirement for the next biennial renewal period.

a. True
b. False

True, [New Jersey Pharmacy Act 45:14-54(d)(3)].

If a pharmacist completes a number of continuing education credit hours in excess of the number required for a biennial period, the Board may allow credits to be carried over to satisfy the pharmacist's continuing education requirement for the next biennial renewal period but shall not be applicable thereafter.


Blog Empty Image

According to Florida Pharmacy Law, which of the following is/are included in a negative drug formulary?


According to Florida Pharmacy Law, which of the following is/are included in a negative drug formulary?

I. Theophylline
II. Conjugated estrogen
III. Dicumarol

a. I only
b. I and II only
c. II and III only
d. All

Answer: d

The negative drug formulary is composed of medicinal drugs which have been specifically determined by the Florida Board of Pharmacy and the Board of Medicine to demonstrate clinically significant biological or therapeutic inequivalence and which, if substituted, could produce adverse clinical effects, or could otherwise pose a threat to the health and safety of patients receiving such prescription medications. The following are included on the negative drug formulary:

(1). Digitoxin.
(2). Conjugated Estrogen.
(3). Dicumarol.
(4). Chlorpromazine (Solid Oral Dosage Forms).
(5). Theophylline (Controlled Release).
(6). Pancrelipase (Oral Dosage Forms).

Substitution by a dispensing pharmacist on a prescription written for any brand name equivalent of a generic named drug product listed on the negative formulary or for a drug within the class of certain dosage forms as listed, is strictly prohibited.

In cases where the prescription is written for a drug listed on the negative drug formulary but a brand name equivalent is not specified by the prescriber, the drug dispensed must be one obtained from a manufacturer or distributor holding an approved new drug application or abbreviated new drug application issued by the Food and Drug Administration, United States Department of Health and Welfare permitting that manufacturer or distributor to market those medicinal drugs or when the former is non-applicable, those manufacturers or distributors supplying such medicinal drugs must show compliance with other applicable Federal Food and Drug Administration marketing requirements.